zm 241385 has been researched along with quinelorane in 1 studies
| Studies (zm 241385) | Trials (zm 241385) | Recent Studies (post-2010) (zm 241385) | Studies (quinelorane) | Trials (quinelorane) | Recent Studies (post-2010) (quinelorane) |
|---|---|---|---|---|---|
| 401 | 3 | 124 | 117 | 0 | 20 |
| Protein | Taxonomy | zm 241385 (IC50) | quinelorane (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.151 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capuano, B; Jörg, M; Lee, KC; Mak, FS; May, LT; Miller, ND; Scammells, PJ | 1 |
1 other study(ies) available for zm 241385 and quinelorane
| Article | Year |
|---|---|
Synthesis and pharmacological evaluation of dual acting ligands targeting the adenosine A2A and dopamine D2 receptors for the potential treatment of Parkinson's disease.
Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Blood-Brain Barrier; CHO Cells; Cricetulus; Dopamine Agonists; Ligands; Male; Rats; Rats, Wistar; Receptors, Dopamine D2 | 2015 |